EditCo Bio, Inc. has announced a strategic licensing agreement with Promega Corporation, granting EditCo access to Promega HiBiT, HaloTag®, and NanoLuc® technologies. These advanced protein-tagging and bioluminescent detection systems will be integrated into EditCo’s CRISPR knock-in services. This collaboration strengthens EditCo’s position as a leader in engineered cell solutions by enabling researchers to generate highly reproducible and reliable gene-edited models for a wide range of applications.
Through this agreement, EditCo will not only facilitate precise genomic knock-ins but also offer functional validation services, ensuring that engineered cells maintain proper protein expression, stability, and activity. These capabilities empower researchers with cell models optimized for mechanistic studies, drug screening, and other advanced applications requiring quantitative protein analysis.
“Our collaboration with Promega underscores EditCo’s commitment to delivering industry-leading CRISPR-engineered cells that go beyond genetic modification by incorporating functional validation,” said Travis Maures, PhD, Chief Scientific Officer at EditCo Bio. “By integrating HiBiT, HaloTag, and NanoLuc into our knock-in workflows, we provide researchers with powerful tools to track protein expression, interactions, and activity with high sensitivity and accuracy. This partnership will accelerate discoveries in functional genomics, drug development, and therapeutic research.”
“This agreement accelerates scientific innovation by providing researchers with advanced cellular models engineered for precise functional analysis,” said Tom Livelli, Promega Vice President, Life Sciences. “Leveraging these technologies enables scientists to probe protein dynamics directly within living cells, empowering deeper insights into complex biological mechanisms.”
Expanding Functional Assays with HiBiT, HaloTag, and NanoLuc
EditCo’s licensing agreement with Promega enables the development of custom-engineered cell lines incorporating these technologies exclusively for research use. Researchers can leverage these advanced tools to create reliable and reproducible cellular models with functional validation, streamlining experimental workflows and increasing data confidence.
For more details on EditCo’s CRISPR Knock-in Services featuring HiBiT, HaloTag, and NanoLuc, visit www.EditCo.bio.
EditCo Bio is a leader in engineered cell solutions, offering high-quality, functionally validated CRISPR-edited cell lines. With a strong foundation in CRISPR genome engineering, EditCo Bio provides researchers with precise, reproducible, and scalable gene-editing services to advance discoveries in cell and gene therapy, drug development, and basic research.
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s portfolio of over 4,000 products supports a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. These tools and technologies have grown in their application over the last 45 years and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors.
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Proceeds to support clinical development of lead first-in-class progra...
